Dr. Kevin Earl McLaughlin, MD

Dr. McLaughlin practices at ENT & Plastic Surgery Specialists of Louisiana in Covington, Louisiana.

Dr. McLaughlin's NPI, 1548269772, was assigned on July 19, 2005. Dr. McLaughlin graduated from Emory School of Medicine in 1994. Dr. McLaughlin's Louisiana license number on file is 13452R.

Dr. McLaughlin's primary practice is ENT & Plastic Surgery Specialists of Louisiana, at 350 Lakeview Ct, Covington, LA 70433-7514. The practice phone is (985) 867-5494.

Dr. McLaughlin's primary practice is ENT & Plastic Surgery Specialists of Louisiana in Covington, Louisiana. Dr. McLaughlin is also affiliated with St. Tammany Parish Hospital. The medical group on file is Our Lady of the Lake Physician Group. Dmand AI also links Dr. McLaughlin to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McLaughlin practices, 7 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. McLaughlin's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. McLaughlin is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. McLaughlin's licenses on file in 3 states: Louisiana, Georgia and Pennsylvania.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. McLaughlin treats.

CMS data shows 924 Medicare services from Dr. McLaughlin across 15 procedure codes in 2024, for 299 Medicare patients. Medicare paid $95,105 for them.

CMS counts 299 Medicare patients who saw Dr. McLaughlin in 2024. The largest group is 65 to 74, with 155 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McLaughlin's median patient age at 66, with 49% women.

In 2024, Dr. McLaughlin wrote 2,432 Medicare Part D claims for 470 patients. 97% of them were for generic drugs. CMS names the drug for 2,231 of them, across 44 drugs with 11 or more claims each, at $47,943 in total drug cost. In 2023, CMS named 1,874 claims across 38 drugs.

Dr. McLaughlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McLaughlin as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 390 general payments to Dr. McLaughlin from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. Optinose US, Inc. paid the most, $183,941. It also lists 37 research payments totaling $75,807 from 2016 to 2019.

Dmand AI lists 1 award for Dr. McLaughlin.

Dr. McLaughlin graduated from Emory School of Medicine in 1994. Dr. McLaughlin is a member of NHS.

Dr. McLaughlin is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.